The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle

Stephan Jacob, Ryan S. Streeper, Donovan L. Fogt, Jason Y. Hokama, Hans J. Tritschler, Günther J. Dietze, Erik J Henriksen

Research output: Contribution to journalArticle

169 Citations (Scopus)

Abstract

Insulin resistance of muscle glucose metabolism is a hallmark of NIDDM. The obese Zucker (falfa) rat-an animal model of muscle insulin resistance- was used to test whether acute (100 mg/kg body wt for 1 h) and chronic (5- 100 mg/kg for 10 days) parenteral treatments with a racemic mixture of the antioxidant α-lipoic acid (ALA) could improve glucose metabolism in insulin- resistant skeletal muscle. Glucose transport activity (assessed by net 2- deoxyglucose [2-DG] uptake), net glycogen synthesis, and glucose oxidation were determined in the isolated epitrochlearis muscles in the absence or presence of insulin (13.3 nmol/l). Severe insulin resistance of 2-DG uptake, glycogen synthesis, and glucose oxidation was observed in muscle from the vehicle-treated obese rats compared with muscle from vehicle-treated lean (Fa/-) rats. Acute and chronic treatments (30 mg · kg -1 · day -1, a maximally effective dose) with ALA significantly (P < 0.05) improved insulin- mediated 2-DG uptake in epitrochiearis muscles from the obese rats by 62 and 64%, respectively. Chronic ALA treatment increased both insulin-stimulated glucose oxidation (33%) and glycogen synthesis (38%) and was associated with a significantly greater (21%) in vivo muscle glycogen concentration. These adaptive responses after chronic ALA administration were also associated with significantly lower (15-17%) plasma levels of insulin and free fatty acids. No significant effects on glucose transporter (GLUT4) protein level or on the activities of hexokinase and citrate synthase were observed. Collectively, these findings indicate that parenteral administration of the antioxidant ALA significantly enhances the capacity of the insulin-stimulatable glucose transport system and of both oxidative and nonoxidative pathways of glucose metabolism in insulin-resistant rat skeletal muscle.

Original languageEnglish (US)
Pages (from-to)1024-1029
Number of pages6
JournalDiabetes
Volume45
Issue number8
StatePublished - 1996

Fingerprint

Thioctic Acid
Skeletal Muscle
Antioxidants
Insulin
Glucose
Muscles
Glycogen
Deoxyglucose
Insulin Resistance
Glucose Transporter Type 4
Zucker Rats
Citrate (si)-Synthase
Hexokinase
Facilitative Glucose Transport Proteins
Nonesterified Fatty Acids
Type 2 Diabetes Mellitus
Animal Models

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Jacob, S., Streeper, R. S., Fogt, D. L., Hokama, J. Y., Tritschler, H. J., Dietze, G. J., & Henriksen, E. J. (1996). The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes, 45(8), 1024-1029.

The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. / Jacob, Stephan; Streeper, Ryan S.; Fogt, Donovan L.; Hokama, Jason Y.; Tritschler, Hans J.; Dietze, Günther J.; Henriksen, Erik J.

In: Diabetes, Vol. 45, No. 8, 1996, p. 1024-1029.

Research output: Contribution to journalArticle

Jacob, S, Streeper, RS, Fogt, DL, Hokama, JY, Tritschler, HJ, Dietze, GJ & Henriksen, EJ 1996, 'The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle', Diabetes, vol. 45, no. 8, pp. 1024-1029.
Jacob S, Streeper RS, Fogt DL, Hokama JY, Tritschler HJ, Dietze GJ et al. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes. 1996;45(8):1024-1029.
Jacob, Stephan ; Streeper, Ryan S. ; Fogt, Donovan L. ; Hokama, Jason Y. ; Tritschler, Hans J. ; Dietze, Günther J. ; Henriksen, Erik J. / The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. In: Diabetes. 1996 ; Vol. 45, No. 8. pp. 1024-1029.
@article{32e52fcef12e4801881b1fab1c6a523f,
title = "The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle",
abstract = "Insulin resistance of muscle glucose metabolism is a hallmark of NIDDM. The obese Zucker (falfa) rat-an animal model of muscle insulin resistance- was used to test whether acute (100 mg/kg body wt for 1 h) and chronic (5- 100 mg/kg for 10 days) parenteral treatments with a racemic mixture of the antioxidant α-lipoic acid (ALA) could improve glucose metabolism in insulin- resistant skeletal muscle. Glucose transport activity (assessed by net 2- deoxyglucose [2-DG] uptake), net glycogen synthesis, and glucose oxidation were determined in the isolated epitrochlearis muscles in the absence or presence of insulin (13.3 nmol/l). Severe insulin resistance of 2-DG uptake, glycogen synthesis, and glucose oxidation was observed in muscle from the vehicle-treated obese rats compared with muscle from vehicle-treated lean (Fa/-) rats. Acute and chronic treatments (30 mg · kg -1 · day -1, a maximally effective dose) with ALA significantly (P < 0.05) improved insulin- mediated 2-DG uptake in epitrochiearis muscles from the obese rats by 62 and 64{\%}, respectively. Chronic ALA treatment increased both insulin-stimulated glucose oxidation (33{\%}) and glycogen synthesis (38{\%}) and was associated with a significantly greater (21{\%}) in vivo muscle glycogen concentration. These adaptive responses after chronic ALA administration were also associated with significantly lower (15-17{\%}) plasma levels of insulin and free fatty acids. No significant effects on glucose transporter (GLUT4) protein level or on the activities of hexokinase and citrate synthase were observed. Collectively, these findings indicate that parenteral administration of the antioxidant ALA significantly enhances the capacity of the insulin-stimulatable glucose transport system and of both oxidative and nonoxidative pathways of glucose metabolism in insulin-resistant rat skeletal muscle.",
author = "Stephan Jacob and Streeper, {Ryan S.} and Fogt, {Donovan L.} and Hokama, {Jason Y.} and Tritschler, {Hans J.} and Dietze, {G{\"u}nther J.} and Henriksen, {Erik J}",
year = "1996",
language = "English (US)",
volume = "45",
pages = "1024--1029",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "8",

}

TY - JOUR

T1 - The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle

AU - Jacob, Stephan

AU - Streeper, Ryan S.

AU - Fogt, Donovan L.

AU - Hokama, Jason Y.

AU - Tritschler, Hans J.

AU - Dietze, Günther J.

AU - Henriksen, Erik J

PY - 1996

Y1 - 1996

N2 - Insulin resistance of muscle glucose metabolism is a hallmark of NIDDM. The obese Zucker (falfa) rat-an animal model of muscle insulin resistance- was used to test whether acute (100 mg/kg body wt for 1 h) and chronic (5- 100 mg/kg for 10 days) parenteral treatments with a racemic mixture of the antioxidant α-lipoic acid (ALA) could improve glucose metabolism in insulin- resistant skeletal muscle. Glucose transport activity (assessed by net 2- deoxyglucose [2-DG] uptake), net glycogen synthesis, and glucose oxidation were determined in the isolated epitrochlearis muscles in the absence or presence of insulin (13.3 nmol/l). Severe insulin resistance of 2-DG uptake, glycogen synthesis, and glucose oxidation was observed in muscle from the vehicle-treated obese rats compared with muscle from vehicle-treated lean (Fa/-) rats. Acute and chronic treatments (30 mg · kg -1 · day -1, a maximally effective dose) with ALA significantly (P < 0.05) improved insulin- mediated 2-DG uptake in epitrochiearis muscles from the obese rats by 62 and 64%, respectively. Chronic ALA treatment increased both insulin-stimulated glucose oxidation (33%) and glycogen synthesis (38%) and was associated with a significantly greater (21%) in vivo muscle glycogen concentration. These adaptive responses after chronic ALA administration were also associated with significantly lower (15-17%) plasma levels of insulin and free fatty acids. No significant effects on glucose transporter (GLUT4) protein level or on the activities of hexokinase and citrate synthase were observed. Collectively, these findings indicate that parenteral administration of the antioxidant ALA significantly enhances the capacity of the insulin-stimulatable glucose transport system and of both oxidative and nonoxidative pathways of glucose metabolism in insulin-resistant rat skeletal muscle.

AB - Insulin resistance of muscle glucose metabolism is a hallmark of NIDDM. The obese Zucker (falfa) rat-an animal model of muscle insulin resistance- was used to test whether acute (100 mg/kg body wt for 1 h) and chronic (5- 100 mg/kg for 10 days) parenteral treatments with a racemic mixture of the antioxidant α-lipoic acid (ALA) could improve glucose metabolism in insulin- resistant skeletal muscle. Glucose transport activity (assessed by net 2- deoxyglucose [2-DG] uptake), net glycogen synthesis, and glucose oxidation were determined in the isolated epitrochlearis muscles in the absence or presence of insulin (13.3 nmol/l). Severe insulin resistance of 2-DG uptake, glycogen synthesis, and glucose oxidation was observed in muscle from the vehicle-treated obese rats compared with muscle from vehicle-treated lean (Fa/-) rats. Acute and chronic treatments (30 mg · kg -1 · day -1, a maximally effective dose) with ALA significantly (P < 0.05) improved insulin- mediated 2-DG uptake in epitrochiearis muscles from the obese rats by 62 and 64%, respectively. Chronic ALA treatment increased both insulin-stimulated glucose oxidation (33%) and glycogen synthesis (38%) and was associated with a significantly greater (21%) in vivo muscle glycogen concentration. These adaptive responses after chronic ALA administration were also associated with significantly lower (15-17%) plasma levels of insulin and free fatty acids. No significant effects on glucose transporter (GLUT4) protein level or on the activities of hexokinase and citrate synthase were observed. Collectively, these findings indicate that parenteral administration of the antioxidant ALA significantly enhances the capacity of the insulin-stimulatable glucose transport system and of both oxidative and nonoxidative pathways of glucose metabolism in insulin-resistant rat skeletal muscle.

UR - http://www.scopus.com/inward/record.url?scp=0029742327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029742327&partnerID=8YFLogxK

M3 - Article

C2 - 8690147

AN - SCOPUS:0029742327

VL - 45

SP - 1024

EP - 1029

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 8

ER -